Hypoxia Inducible Factor-1 Protects Against Nitrate Tolerance and Stunning in Rabbit Cardiac Myocytes Tao TanHarvey R. Weiss OriginalPaper 20 April 2010 Pages: 95 - 106
Additive Effect of TAK-491, a New Angiotensin Receptor Blocker, and Pioglitazone, in Reducing Myocardial Infarct Size Yumei YeKyle T. KeyesYochai Birnbaum OriginalPaper 09 April 2010 Pages: 107 - 120
Granulocyte-colony Stimulating Factor Treatment of Chronic Myocardial Infarction Ruy A. N. LouzadaPatricia F. OliveiraJoao P. S. Werneck-de-Castro OriginalPaper 02 February 2010 Pages: 121 - 130
Hydralazine does not Ameliorate Nitric Oxide Resistance in Chronic Heart Failure Yuliy Y. ChirkovMichele De SciscioJohn D. Horowitz OriginalPaper 20 May 2010 Pages: 131 - 137
Application of Direct Renin Inhibition to Chronic Kidney Disease Christian W. Mende ReviewPaper Open access 20 May 2010 Pages: 139 - 149
Cardiovascular Risks of Anemia Correction with Erythrocyte Stimulating Agents: Should Blood Viscosity Be Monitored for Risk Assessment? Seul-Ki JeongYoung I. ChoRobert S. Rosenson OriginalPaper 01 June 2010 Pages: 151 - 160
Practical Strategies for the Management of Anticoagulation Therapy: Unsolved Issues in the Cardiac Catheterization Laboratory José G. DíezJames M. Wilson ReviewPaper 14 April 2010 Pages: 161 - 174
Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial Michael G. HennericiMichiel L. BotsPierre Jean Touboul OriginalPaper Open access 20 May 2010 Pages: 175 - 180
A Multicenter, Eight-Week Treatment, Single-Step Titration, Open-Label Study Assessing the Percentage of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target with Atorvastatin Starting Doses of 10 mg, 20 mg and 40 mg Cheol Whan LeeSang-Hong BaekHyo-Soo Kim OriginalPaper 10 April 2010 Pages: 181 - 188
